Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Profit After Tax of -$4.8 million for Q4 2025, down 141.16% year-on-year from $11.6 million in Q4 2024, and down 650.31% on a QoQ basis from -$638000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Profit After Tax data on file, last reported at -$4.8 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 141.16% year-over-year to -$4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$9.7 million (down 2134.4% YoY), and the FY2025 full-year result was -$9.7 million, down 2134.17% from the prior year.
- Profit After Tax for Q4 2025 stood at -$4.8 million, down from -$638000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $12.8 million in Q1 2024 and bottomed at -$8.0 million in Q3 2022.
- The 5-year median for Profit After Tax is -$4.2 million (2021), against an average of -$3.3 million.
- Peak annual rise in Profit After Tax reached 312.11% in 2024, while the deepest fall reached 207.18% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$4.3 million in 2021, then tumbled by 58.04% to -$6.7 million in 2022, then soared by 60.12% to -$2.7 million in 2023, then climbed by 25.99% to -$2.0 million in 2024, then plunged by 141.16% to -$4.8 million in 2025.
- The last three Profit After Tax figures came in at -$4.8 million (Q4 2025), -$638000.0 (Q3 2025), and -$3.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -4.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -638,000.00 |
| Jun 30, 2025 | -3.15 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | -5.74 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | 12.84 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -5.44 Mn |
| Mar 31, 2023 | -6.05 Mn |
| Dec 31, 2022 | -6.73 Mn |
| Sep 30, 2022 | -7.99 Mn |
| Jun 30, 2022 | -5.06 Mn |
| Mar 31, 2022 | -3.60 Mn |
| Dec 31, 2021 | -4.26 Mn |
| Sep 30, 2021 | -4.22 Mn |
| Jun 30, 2021 | -3.92 Mn |
| Mar 31, 2021 | -4.91 Mn |
| Dec 31, 2020 | -3.33 Mn |
| Sep 30, 2020 | -5.84 Mn |
| Jun 30, 2020 | -4.83 Mn |
| Mar 31, 2020 | -3.80 Mn |
| Dec 31, 2019 | -3.58 Mn |
| Sep 30, 2019 | -1.79 Mn |
| Jun 30, 2019 | -4.70 Mn |
| Mar 31, 2019 | -2.63 Mn |
| Dec 31, 2018 | -2.98 Mn |
| Sep 30, 2018 | -2.75 Mn |
| Jun 30, 2018 | -2.59 Mn |
| Mar 31, 2018 | -1.57 Mn |
| Dec 31, 2017 | -2.29 Mn |
| Sep 30, 2017 | -2.35 Mn |
| Jun 30, 2017 | -1.60 Mn |
| Mar 31, 2017 | -806,000.00 |
| Dec 31, 2016 | -1.14 Mn |
| Sep 30, 2016 | -502,000.00 |
| Jun 30, 2016 | -724,000.00 |
| Mar 31, 2016 | -420,000.00 |
| Dec 31, 2015 | -540,000.00 |
| Sep 30, 2015 | -123,000.00 |
| Jun 30, 2015 | -173,000.00 |
| Mar 31, 2015 | 177,000.00 |
| Dec 31, 2014 | 1.39 Mn |
| Sep 30, 2014 | 380,000.00 |
| Jun 30, 2014 | -750,000.00 |
| Mar 31, 2014 | -3.19 Mn |
| Dec 31, 2013 | 1.11 Mn |
| Sep 30, 2013 | -1.77 Mn |
| Jun 30, 2013 | 6.61 Mn |
| Mar 31, 2013 | -4.11 Mn |
| Dec 31, 2012 | -6.51 Mn |
| Sep 30, 2012 | -764,000.00 |
| Jun 30, 2012 | -602,000.00 |
| Mar 31, 2012 | 2.72 Mn |
| Dec 31, 2011 | 3.51 Mn |
| Sep 30, 2011 | -3.14 Mn |
| Jun 30, 2011 | -348,000.00 |
| Mar 31, 2011 | 4.67 Mn |
| Dec 31, 2010 | -6.58 Mn |
| Sep 30, 2010 | 1.69 Mn |
| Jun 30, 2010 | -2.57 Mn |